Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: case report of incidentally detected Cowden syndrome

BMC Cancer. 2019 Oct 29;19(1):1014. doi: 10.1186/s12885-019-6272-2.

Abstract

Background: Somatic PTEN mutation occurs in a proportion of ovarian endometrioid carcinomas. However, these cancers have seldom been reported in diseases associated with germline PTEN variants, such as Cowden syndrome (CS).

Case presentation: The present case was a 39-year-old woman with a left ovarian carcinoma who demonstrated a germline splice variant of PTEN (c.1026 + 1G > T) following genome-wide whole exome sequencing of her germline DNA. Histology of her resected tumor revealed endometrioid carcinoma of the same type as a right ovarian cancer resected eight years previously. These tumors showed null immunostaining for PTEN. She was genetically diagnosed with CS. Despite her clinical examinations had demonstrated several characteristic findings of CS, including mammary fibroma, esophageal and skin papilloma, colonic hamartoma, uterine myoma, and lipoma, the clinicians could not approach this diagnosis.

Conclusion: Ovarian endometrioid carcinoma is generally thought to develop from endometrial tissue menstruated from the uterus and implanted on the ovary. To date, ovarian cancers have not been listed as CS-related cancers; however, ovarian endometrioid cancer can have a potential association with CS in endometriosis cases.

Keywords: Endometrioid carcinoma; Germline variant; Ovarian; PTEN.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aorta, Abdominal
  • Carcinoma, Endometrioid / complications*
  • Carcinoma, Endometrioid / pathology
  • Carcinoma, Endometrioid / surgery
  • Exome Sequencing
  • Female
  • Germ-Line Mutation
  • Hamartoma Syndrome, Multiple / complications*
  • Hamartoma Syndrome, Multiple / genetics*
  • Humans
  • Hysterectomy
  • Japan
  • Lymph Node Excision
  • Ovarian Neoplasms / complications*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery
  • Ovariectomy
  • PTEN Phosphohydrolase / genetics*
  • Pelvis
  • Treatment Outcome

Substances

  • PTEN Phosphohydrolase
  • PTEN protein, human